Mixed Results Seen With 'Off-Label' Use of Antipsychotics
Non-FDA-approved use of drugs showed limited benefits and some harm in large reviewContinue Reading
Non-FDA-approved use of drugs showed limited benefits and some harm in large reviewContinue Reading
‘What-difference-will-it-make’ mindset linked to low rates of testing among poorContinue Reading
Full assessment on brands such as Yaz, Yasmin is yet to come, agency saysContinue Reading
Some doctors lack training and certification, botch operations, plastic surgeons sayContinue Reading
Study finds decline from years past but ‘we have a long way to go,’ advocate saysContinue Reading
Having a nurturing mother may protect against health risks associated with poverty, study findsContinue Reading
Too little of it raises risk of prostate cancer, diabetes, rheumatoid arthritis, and other diseases, study saysContinue Reading
But they’re still less likely than U.S.-born women to get breast cancer screeningContinue Reading
Depressed Hispanic breast cancer survivors less likely to get checked for ovarian tumors, study findsContinue Reading
Drug first approved in 2007Continue Reading
Knowledge gap affects more than 1 million Americans with atrial fibrillation, survey showsContinue Reading
Yet blacks and Hispanics are less likely to get the diseaseContinue Reading
Incidents are rare but consumers need to be informed and carefulContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.